- Home
- CTNM vs EVAC Comparison
CTNM vs EVAC Comparison
Compare CTNM & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNM | EVAC |
|---|---|---|
| Founded | 2009 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Fluid Controls |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.7M | 592.7M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CTNM | EVAC |
|---|---|---|
| Price | $12.58 | $10.31 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 460.7K | 141.1K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.60 | $9.90 |
| 52 Week High | $17.79 | $10.33 |
Technical Indicators
Market Signals| Indicator | CTNM | EVAC |
|---|---|---|
| Relative Strength Index (RSI) | 32.81 | 59.95 |
| Support Level | $11.73 | $10.25 |
| Resistance Level | $13.54 | N/A |
| Average True Range (ATR) | 0.90 | 0.02 |
| MACD | -0.29 | -0.00 |
| Stochastic Oscillator | 23.60 | 60.00 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares
EQV Ventures Acquisition Corp II is a blank check company.